Grupo Aval announces availability of Q3 2026 consolidated results report

AVAL•2026-11-12

Grupo Aval published its consolidated results report for the period ended September 30, 2026. A conference call to discuss the results is scheduled for today.

1. Results report

Grupo Aval published its consolidated results report for the period ended September 30, 2026. A conference call to discuss the results is scheduled for today.

Sources

Grupo Aval announces availability of Q3 2026 consolidated results report

Sec

Grupo Aval announces availability of Q3 2026 consolidated results report

1. Results report

Related News

Mangoceuticals partners with T7X to offer tokenized preferred stock

Century Therapeutics Q3 net loss narrows, beats analyst expectations

Yarrow Bioscience posts Q3 net loss

Sources

Grupo Aval announces availability of Q3 2026 consolidated results report

Spyglass Pharma target price raised to $44 from $39 by Raymond James

Traws Pharma reports final Phase 2a COVID drug data vs Paxlovid